Obesity is a serious global health problem due to its increasing prevalence and comorbidities, but its treatments are limited. The serotonin 2C receptor (5-HT2CR), a G protein-coupled receptor, activates pro-opiomelanocortin (POMC) neurons in the arcuate nucleus of hypothalamus (ARH) to reduce appetite and weight gain. However, several 5-HT analogs targeting this receptor, e.g. lorcaserin, suffer from diminished efficacy to reduce weight after prolonged administration. Here we show that barbadin, a novel β-arrestin/β2-adaptin inhibitor, can prevent 5-HT2CR internalization in cells and potentiate long-term effects of lorcaserin to reduce appetite and body weight in male mice. Mechanistically, we demonstrate that barbadin co-treatment can effectively maintain the sensitivity of the 5-HT2CR in POMCARH neurons, despite prolonged lorcaserin exposure, thereby allowing these neurons to be activated through opening the transient receptor potential cation channels. Thus, our results prove the concept that inhibitio...